CD276 and cancer: In addition, CD276 was found to be associated with nonspecific immunomodulatory effects, such as neutrophil degranulation and signaling by interleukins, in certain types of cancer, including KICH, LAML, LGG, LIHC, PCPG, READ, STAD and UVM (Supplementary Fig. S7).